AT278 and NovoRapid® in Glucose Clamp Study

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 2, 2020

Primary Completion Date

June 3, 2021

Study Completion Date

June 11, 2021

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG

AT278

Concentrated rapid acting insulin aspart

DRUG

NovoRapid

Rapid acting insulin aspart

Trial Locations (1)

Clinical Trials Unit, Medical University of Graz, Graz

All Listed Sponsors

lead

Arecor Limited

INDUSTRY

NCT04660305 - AT278 and NovoRapid® in Glucose Clamp Study | Biotech Hunter | Biotech Hunter